HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis.

Abstract
Arsenic can induce apoptosis and is an efficient drug for the treatment of acute promyelocytic leukemia. Currently, clinical studies are investigating arsenic as a therapeutic agent for a variety of malignancies. In this study, Hodgkin/Reed-Sternberg (HRS) cell lines served as model systems to characterize the role of nuclear factor-kappaB (NF-kappaB) in arsenic-induced apoptosis. Arsenic rapidly down-regulated constitutive IkappaB kinase (IKK) as well as NF-kappaB activity and induced apoptosis in HRS cell lines containing functional IkappaB proteins. In these cell lines, apoptosis was blocked by inhibition of caspase-8 and caspase-3-like activity. Furthermore, arsenic treatment down-regulated NF-kappaB target genes, including tumor necrosis factor-alphareceptor-associated factor 1 (TRAF1), c-IAP2, interleukin-13 (IL-13), and CCR7. In contrast, cell lines with mutated, functionally inactive IkappaB proteins or with a weak constitutive IKK/NF-kappaB activity showed no alteration of the NF-kappaB activity and were resistant to arsenic-induced apoptosis. A direct role of the NF-kappaB pathway in arsenic-induced apoptosis is shown by transient overexpression of NF-kappaB-p65 in L540Cy HRS cells, which protected the cells from arsenic-induced apoptosis. In addition, treatment of NOD/SCID mice with arsenic trioxide induced a dramatic reduction of xenotransplanted L540Cy Hodgkin tumors concomitant with NF-kappaB inhibition. We conclude that inhibition of NF-kappaB contributes to arsenic-induced apoptosis. Furthermore, pharmacologic inhibition of the IKK/NF-kappaB activity might be a powerful treatment option for Hodgkin lymphoma.
AuthorsStephan Mathas, Andreas Lietz, Martin Janz, Michael Hinz, Franziska Jundt, Claus Scheidereit, Kurt Bommert, Bernd Dorken
JournalBlood (Blood) Vol. 102 Issue 3 Pg. 1028-34 (Aug 01 2003) ISSN: 0006-4971 [Print] United States
PMID12676792 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arsenicals
  • Arsenites
  • NF-kappa B
  • Oxides
  • Sodium Compounds
  • sodium arsenite
  • Protein Serine-Threonine Kinases
  • CHUK protein, human
  • Chuk protein, mouse
  • I-kappa B Kinase
  • IKBKB protein, human
  • IKBKE protein, human
  • Ikbkb protein, mouse
  • Ikbke protein, mouse
  • Arsenic
  • Arsenic Trioxide
Topics
  • Animals
  • Apoptosis (drug effects)
  • Arsenic (pharmacology)
  • Arsenic Trioxide
  • Arsenicals (pharmacology)
  • Arsenites (pharmacology)
  • Down-Regulation
  • Gene Expression Profiling
  • Hodgkin Disease (metabolism, pathology)
  • Humans
  • I-kappa B Kinase
  • Mice
  • Mice, SCID
  • NF-kappa B (antagonists & inhibitors)
  • Oxides (pharmacology)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors)
  • Reed-Sternberg Cells (drug effects, pathology)
  • Sodium Compounds (pharmacology)
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: